Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer.

Status:
Active, not recruiting

Trial end date:
2023-05-01

Target enrollment:

Participant gender:

The purpose of this study is to look at patient outcomes when docetaxel is started prior to ADT with degarelix.

Phase 2

Medical University of South Carolina

Ferring Pharmaceuticals

Docetaxel